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Australia.Introduction
Gaps between radiofrequency (RF) ablation lesions are the
culprits for failed pulmonary vein isolation (PVI) leading to
recurrent atrial arrhythmias. The ability to directly visualize in
real time and eliminate interlesion gaps may improve the success
of RF ablation by achieving contiguous linear ablation lesion
sets. We aimed to describe to the best of our knowledge the ﬁrst
reported clinical case using the direct endocardial visualization
(DEV) ablation catheter (Voyage Medical Inc., Redwood City,
CA) to successfully reisolate pulmonary veins (PVs) by visually
targeting interlesion gaps under direct endoscopic visualization
during a clinical trial undertaken at our institution.
The DEV catheter uniquely delivers RF energy using the
virtual electrode.1 The virtual electrode can be conceptualized
as the intervening saline column within the hood aperture in
contact with the endocardial surface, thus preserving visual-
ization of the target endocardium during ablation. The ﬁber-
scopic camera is located at the distal hood to visualize the
endocardial surface as blood is purged away by the saline
irrigation to create an unobstructed ﬁeld of view (FOV).1
Case report
A 60-year-old man with recurrent drug-refractory sympto-
matic paroxysmal atrial ﬁbrillation (AF) was referred forKEYWORDS Ablation technology; Direct endocardial visualization catheter;
Ablation catheter; Virtual electrode; Atrial ﬁbrillation; Atrial arrhythmia;
Pulmonary vein isolation; Interlesion gap; Radiofrequency ablation;
Electroanatomic mapping
ABBREVIATIONS AF ¼ atrial fibrillation; DEV ¼ direct endocardial
visualization; EAM ¼ electroanatomic; EGM ¼ electrogram; FOV ¼ field
of view; IR ¼ infrared; LSPV ¼ left superior pulmonary vein; NFUS ¼
near-field ultrasound; PV ¼ pulmonary vein; RF ¼ radiofrequency;
VGLA ¼ visually guided laser ablation
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).repeat PVI. His debilitating symptoms had returned despite
multiple electrical cardioversions and pharmacologic thera-
pies necessitating a repeat ablation. He had a mildly dilated
left atrium (LA) and normal left ventricular systolic function.
An initially successful single-ring PVI ablation had been
performed 6 months earlier using a conventional irrigated-tip
catheter.2Ablation procedural details
An 8.5Fr medium-curve Agilis sheath and 8.5Fr SL1
guiding sheath were used to perform double transseptal
punctures using a Brockenbrough needle. The Agilis was
upgraded to a 14Fr sheath to accommodate the DEV catheter.
The 3-dimensional electroanatomic (EAM) geometry was
created using NavX (St. Jude Medical Inc., St. Paul, MN) and
Lasso catheters at baseline in order to subsequently validate
the map created by the direct visualization catheter. Activa-
tion mapping was performed using the 4 metal plate contact
electrodes conﬁgured to provide 4 pairs of contact bipolar
electrograms (EGMs) across the distal hood face apposed to
the endocardial surface. Online Supplemental Movie 1 is a
ﬂuoroscopic recording in the right anterior oblique view of
the circular mapping catheter (Halo, Biosense Webster Inc.,
Diamond Bar, CA) positioned in the left superior pulmonary
vein (LSPV) and the DEV catheter positioned close to the
ostium of the LSPV. A 5-mm decapolar catheter was
positioned in the coronary sinus. A temperature probe was
used to monitor esophageal temperature during ablation.
PVI using the DEV ablation catheter integrated with
3-dimensional EAM and bipolar EGMs
Figure 1 shows the FOV through the DEV catheter (2.8-
mm central hood aperture and 6.8-mm diameter) to enable
visual mapping of the anatomic gap. An activation map of
the LA created using the contact bipolar EGMs of the DEV
catheter revealed earliest competing activation on the mid-
posterior LA wall.pen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2014.12.009
Figure 1 Field of view (FOV) through the direct endocardial visualiza-
tion catheter measuring 2.8 mm across the central hood aperture and 6.8-
mm-diameter hood face. The FOV facilitates visual mapping for the
anatomic gap of electrical reconnection embedded in the region of earliest
activation. Local endocardial tissue electrogram (EGM) signals were
recorded by 4 metal-plate contact electrodes situated on the hood face.
The electrodes were conﬁgured by an EP recording system (Prucka) to
provide 4 pairs of contact bipolar EGMs across the hood face and displayed
on the EP recording system (Prucka). A Lasso electrode is seen in contact
with the left superior pulmonary vein tissue in the FOV.
KEY TEACHING POINTS
 Direct Endoscopic Ablation Catheter utilized a
ﬁberscopic camera at the distal hood to visualize
endocardial surface as blood is purged away by the
saline irrigation to create an unobstructed ﬁeld of
view (FOV).
 Real-time full-color direct endocardial visualization
of partially or non-ablated inter-lesion gaps
associated with contact bipolar EGM signals of
surviving myocardium was clinically feasible.
Electrically reconnected gaps were visually and
electrically mapped.
 Electrically reconnected visual gaps were
successfully ablated by delivering radiofrequency
energy using the virtual electrode under visual
guidance that resulted in electrical re-isolation of
the pulmonary veins and posterior left atrium
following prior single ring pulmonary vein isolation
procedure.
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earliest electrical conduction into the single ring.
The activation map showed the earliest competing activation
represented by the white strip was located on the mid-posterior
LA wall. This was targeted ﬁrst and ablated under visual
guidance. After abolition of the visual gap, the next earliest
breakthrough was localized to the anterior aspect of the left PV/
left atrial appendage (LAA) ridge. The fractionated PV poten-
tials recorded by the hood-face electrodes at the ridge suggested
a region of electrically reconnected tissue (Figure 2A). EGMs
recorded in this region correlated with the visually pink gap of
residual viable endocardium as seen through the FOV (see
Online Supplemental Movie 2). This was characteristic for an
electrically reconnected anatomic gap on the old ablation line
ﬂanked by regions of old electrically inert ablated scar. Chroni-
cally ablated scar appeared as white endocardial tissue through
the FOV over the left PV ridge (Figure 2B).
Abolition of visual gap by RF ablation delivered via
the virtual electrode successfully electrically
reisolated both sets of PVs
RF ablation lesions were delivered via the virtual electrode of
the DEV ablation catheter targeting the visual anatomic gap
with the earliest fractionated EGM signals. A Stockert RF
generator (Biosense Webster) was used to deliver RF power
titrated from 7 W up to 15 W for durations of 20 to 40
seconds. A saline irrigation rate of 10–15 mL/min was used
during visual mapping, and a higher irrigation rate of 25mL/min
was delivered during ablations using the CoolFlow pump
(Biosense Webster).
Figure 2 highlights the real-time correlations between (1)
direct full-color endoscopic visualization of the pink inter-
lesion gap between ablated tissue; (2) bipolar EGMsrecorded at the gap indicative of electrical conduction and
tissue viability; and (3) ablation lesions delivered by the
DEV catheter localized on the NavX EAM map. When
interpreted in conjunction, these images were helpful in the
guidance and delivery of RF energy at the targeted gap to
successfully electrically reisolate the PVs as well as the
posterior LA wall.Conﬁrmation of PVI with dissociated signals and
differential pacing in the LAA conﬁrming
far-ﬁeld appendage signals
Figure 3A shows the absence of EGM from the DEV catheter
positioned within the LSPV, conﬁrming successful reisola-
tion. The acutely blanch whitish appearance of the ablated
gap at this location after electrical reisolation as seen through
the FOV is represented (Figure 3A). The patient reverted to
normal sinus rhythm during ablation at the LSPV/LAA
ridge. At 12-month follow-up, the patient remained asymp-
tomatic and had documented arrhythmia-free 7-day Holter
monitoring.Discussion
Voyage IRIS DEV ablation catheter
Voyage Medical Inc was a startup company founded in late
2006. It received 3 rounds of venture funding through 2012.
The initial funding was in support of a system developed to
guide transseptal puncture under direct visualization.3 This
Figure 2 A: Electrogram (EGM) captured by direct endocardial visualization DEV hood-face electrodes at the anterior left superior pulmonary vein (LSPV)/
left atrial appendage (LAA) ridge. Pulmonary vein potentials were recorded over pink viable endocardium at the site of the interlesion gap (between regions of
partially blanched tissue). B: Chronically ablated scar during visual mapping adjacent to the ridge. The electrode bipolar EGM shows attenuated amplitude
signals corresponding to fully blanched whitish endocardial tissue as seen through the ﬁeld of view (FOV). CS ¼ coronary sinus.
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study for cavotricuspid isthmus ﬂutter ablation by Dr. Petr
Neužil and Dr. Vivek Reddy at Na Homolka Hospital, Czech
Republic, in 2008.4
The company subsequently enrolled approximately 50
patients in clinical feasibility trials between 2009 and 2012
for ablation of cavotricuspid isthmus ﬂutter and paroxysmal
AF. The patients were enrolled and treated in Bordeaux,
France, the Czech Republic, and Westmead Hospital in
Sydney, Australia. The company was in the process ofFigure 3 A: Electrograms (EGMs) consistent with electrical reisolation of the lef
the left superior pulmonary vein (LSPV) ridge. The region was ablated using the vi
previously pink appearance of the gap is replaced by blanched whitish color ablated
reisolation. B: Endocardial trabeculae appearance of the left atrial appendage (LA
virtual electrode while the DEV catheter was positioned in the LAA. Upon pacing
Lasso were seen to be pulled in from the LAA.implementing an improved CMOS image sensor, but when
ﬁnancing became an overwhelming challenge the company
ceased operations in early 2013.
Advantages of DEV
It was clinically feasible to identify partially or nonablated
interlesion gaps associated with EGMs of surviving myocar-
dium. An important consideration was that direct visual-
ization provided real-time assessment of tissue contact,
which was superior to relying on indirect modalitiest-sided pulmonary veins after successful abolition of visual interlesion gaps at
rtual electrode of the direct endocardial visualization (DEV) catheter, and the
myocardium seen on the ﬁeld of view (FOV) after successful pulmonary vein
A) as seen through the FOV. Differential pacing was performed using the
through the saline bridge of the virtual electrode, the far-ﬁeld signals on the
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Furthermore, contact bipolar EGM signals provided addi-
tional useful local tissue electrophysiologic information in
terms of amplitude and timing when the hood face (elec-
trode) attained good apposition with the endocardial inter-
face. Evaluation of local EGM amplitude, morphology, and
timing were valuable aids during mapping and ablation to
optimize lesion creation at the target anatomic site. During
our limited experience, we determined that the ability to
observe real-time blanching was advantageous because one
could ensure that visually contiguous lesions had been
created before proceeding to the next linear ablation.
Termination of RF delivery was possible upon observing
evidence of overheating, which included the formation of
visualized steam bubbles at the electrode–tissue interface and
thrombus formation as seen through the FOV, which were
used as visual cues to terminate RF ablation.Other direct visualization ablation technologies
Two visualization catheters have been previously described:
the laser endoscopic ablation system (CardioFocus Inc.,
Marlborough, MA) and the ﬁberoptic infrared (IR) endo-
scope system (CardioOptics Inc., Boulder, CO).
The CardioOptics system uses a steerable ﬁberoptic IR
endoscope on a 7Fr ﬂexible catheter that is percutaneously
deployed to visualize through ﬂowing blood. The IR endo-
scope (2900-ﬁber imaging bundle, wavelength 1620 nm,
frame rate 10–30 per second, 320  256 pixels) was
advanced to the coronary sinus ostium and branches by
direct visualization of anatomic landmarks by Nazarian et al5
in a closed-chest canine model. Knight et al6 successfully
deployed the IR endoscopic catheter to directly visualize the
electrode–endocardial interface during RF ablation and
characterized ablation lesion formation. However, clinical
endocardial visualization using IR wavelengths has the
disadvantage of losing color ﬁdelity and limited penetrance.
A balloon-tipped ﬁberoptic endoscope was initially used to
visualize the ostium of the coronary sinus and RF lesion
formation.7 The latex balloon covering the distal tip provided
a visual ﬁeld of 15–20 mm in diameter when the balloon was
inﬂated to a volume of 7–10 mL. Use of the ﬁberoptic direct
visualization catheter for guiding endocardial RF lesion place-
ment, estimating lesion size, and identifying interlesion gaps was
subsequently described by Eversull et al8 in an ovine model.
CardioFocus is the latest generation of novel laser balloon
ablation systems developed for performing PVI for the
treatment of AF. This visually guided laser ablation (VGLA)
catheter is a compliant, nonsteerable, variable-diameter
balloon that delivers laser energy around the PV ostium
under real-time endoscopic visualization. A ﬂuid-ﬁlled
balloon is cooled with continuous circulating saline that
clears the blood in front of the catheter to create a bloodless
balloon–tissue interface for ablation. FOV is obtained
through a 500-mm diameter 2Fr ﬁberoptic endoscope posi-
tioned proximal to the balloon. Endoscopic real-time visual-
ization permits assessment of tissue blanching andoptimization of deployed balloon placement at the target
PV antrum as efﬁcacy of laser balloon ablation is dependent
on good contact around the balloon circumference.9,10 An
arc generator guided by endoscopic visualization emits a
green targeting laser beam projected in arcs of approximately
301 onto the balloon–tissue contact. A diode laser delivers
980-nm laser energy to create point-by-point lesions at the
target site using 5.5–18 W for 20–30 seconds depending on
tissue depth and proximity to the esophagus.11
Dukkipati et al12 reported VGLA resulted in a high rate of
durable PVI with a similar clinical efﬁcacy to that of RF
ablation in a multicenter, multioperator clinical study. More
recently, the results of the ﬁrst 200-patient multicenter
clinical experience using VGLA for PVI in paroxysmal AF
patients involving 33 operators across 15 centers showed
98.8% of targeted PVs were isolated.13 There were no
complications involving stroke/transient ischemic attack,
atrio-esophageal ﬁstulas, or signiﬁcant PV stenosis. Cardiac
tamponade was reported in 2% and phrenic nerve palsy in
2.5%. Importantly, 60.2% (95% conﬁdence interval 52.7%–
67.4%) were free from atrial arrhythmias after 1 or 2
procedures off medications, suggesting the VGLA catheter
has a efﬁcacy and safety proﬁle similar to that of RF ablation
for PVI.13 However, as with any new technology, there is an
operator learning curve. A limitation of the VGLA catheter is
its limited ability to assess lesion depth and determine
whether a transmural lesion has been created.Challenges and limitations with
direct visualization systems
DEV using a catheter has been introduced with a variety of
different technologies. The critical difﬁculty with endocar-
dial visualization is the presence of blood obscuring the
endocardium. This difﬁculty has been addressed by either
imaging using IR wavelengths that penetrate through blood
for short distances or evacuating blood from the FOV using a
balloon or continuous saline irrigation.
Endocardial visualization using IR wavelengths has the
disadvantage of losing color ﬁdelity, but balloon and saline
irrigation techniques preserve full-color visualization of the
endocardial surface. In the case of the DEV ablation catheter,
RF energy delivery using a standard metal contact electrode
would directly obstruct the FOV. This led to the concept of using
a virtual electrode for RF energy delivery via a saline bridge to
the target tissue and simultaneously preserving the FOV during
ablation.1 Unfortunately, 1 of the key limitations for the DEV
catheter is the technical difﬁculties in ﬁxing the hood orthogonal
to the tissue surface. This is essential to achieving a good seal
between the open hood aperture and the target–tissue interface in
order to exclude blood from the FOV, thus preserving RF energy
within the virtual electrode and maintaining visualization of the
target tissue. Adequate hood aperture–tissue apposition may not
be possible at uneven anatomic sites such as trabeculated atrial/
ventricular tissue, the LAA ridge, and the oriﬁce of PVs.
FOV is relatively limited despite a 6.8-mm-diameter hood
face (Figure 1). Therefore, assessment of the catheter’s
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requiring concurrent ﬂuoroscopic and EAM imaging guid-
ance. The need to maintain an unobstructed FOV during
mapping and ablation has the potential for extra saline
volume loading, which may be a contraindication for patients
with unstable heart failure, and may necessitate empiric
urinary catheterization. In addition, the larger 14Fr diameter
sheath may increase the risk for local vascular injury at the
site of percutaneous access. Finally, the presence of visual
blanching on the endocardial surface did not necessarily
imply a transmural lesion; hence, electrical signals were
beneﬁcial to rectify the efﬁcacy and adequacy of ablations.Future technologies to overcome the limitations of
direct visualization systems
The ultimate goal is to improve the long-term success of RF
ablation and reduce the need for repeat procedures by
delivering better lesions that are durable, transmural, and
contiguous. However, delivery of more energy to create
deeper and more efﬁcacious lesions must be performed
without compromising the safety of the procedure. Progress
certainly has been made with the reﬁnement of ablation
techniques and ongoing development of technologies aimed
at achieving better tissue contact during ablation, namely, the
use of a long steerable sheath, high-frequency jet ventilation
to reduce the negative effects of respiration on catheter
stability,14,15 and, more recently, real-time contact force
catheters integrated with 3-dimensional EAM mapping.16–18
Intracardiac echocardiography monitors lesion formation by
detecting increased tissue echogenicity associated with lesion
edema on ultrasound images. A recent novel technologic
development is the near-ﬁeld ultrasound (NFUS) ablation
catheter, which uses 4 ultrasound transducers at the catheter
tip with an 8Fr open-irrigated conventional RF ablation
catheter. The NFUS ablation catheter obviates the need for
extruding blood from the FOV and may potentially overcome
numerous limitation attributed to the visualization catheter by
virtue of its ability to assess catheter–tissue contact, determine
target tissue thickness, and assess the depth of real-time RF
lesion formation. Wright et al19 demonstrated the practical
utility of NFUS imaging to assess lesion size and transmurality,
as well as visualization of intramyocardial gas formation before
steam pop occurrence to improve ablation safety.20
Contact force sensing ablation catheter technologies, such
as TactiCath (Biotronik Inc., Berlin, Germany) and Smart-
Touch (Biosense Webster), have the potential to obviate the
need for visualization to assess tissue contact pressure.
Optimal contact force (20–40g) at the electrode–tissue inter-
face can be predictably applied independent of catheter
orientation and without the need for direct visual conﬁrma-
tion.18,21–25 Furthermore, the integration of imaging technol-
ogies, including real-time magnetic resonance imaging and
computed tomographic guidance, with contact force sensing
catheters may facilitate targeting of interlesion gaps and
achieve durable ablation lesion sets. Future advances in real-
time imaging visualization of ablation lesions on bothcomputed tomography26,27 and magnetic resonance imag-
ing28,29 may be the new paradigm that has the potential to
overcome most of the difﬁculties associated with direct
visualization ablation catheters for effective and safe abla-
tions. It is hoped that future technologies will allow the
proceduralist to directly visualize lesion formation as energy is
being delivered with an imaging modality that possesses high
spatial and temporal resolution to readily assess the adequacy
of lesion depth, ensures that transmurality is achieved with
optimal contact force, and accurately targets and then ablates
interlesion gaps to create contiguous lesion sets.
In conclusion, interlesion electrically reconnected gaps
were visually and electrically mapped under real-time, full-
color endocardial visualization. Successful ablation of visual
gaps using the virtual electrode under visual guidance
resulted in electrical reisolation of the PVs and posterior
LA after prior single-ring PVI for paroxysmal AF.
Appendix
Supplementary Data
Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.hrcr.2014.
12.009.
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